Jump to content

Julphar: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
revert blatant spam
No edit summary
Line 1: Line 1:
{{advert|date=December 2010}}
{{Notability|date=May 2010}}

{{Infobox company|
{{Infobox company|
company_name = Gulf Pharmaceutical Industries (Julphar) |
company_name = Gulf Pharmaceutical Industries (Julphar) |
company_logo = [[File:Julphar-logo.jpg‎|122 × 80 pixels|Gulf Pharmaceutical Industries (Julphar) corporate logo]] |
company_logo = [[File:Julphar-logo.jpg‎|122 × 80 pixels|Gulf Pharmaceutical Industries (Julphar) corporate logo]] |
company_type = [[Public shareholding company|Public]] |
company_type = [[Public shareholding company|Public]] |
company_slogan = Working together for a better health|
company_slogan = Well Positioned To Meet Tomorrow’s Challenges|
foundation = 1980 |
foundation = 1980 |
location = [[Ras Al Khaimah|RAK]], [[United Arab Emirates|UAE]] |
location = [[Ras Al Khaimah|RAK]], [[United Arab Emirates|UAE]] |
key_people = [[Sheikh Faisal Bin Saqar Al Qasimi]] [[Chairman of the Board]]<br/> Dr. Ayman Ahmed Sahli [[General Manager|GM]]|
key_people = [[Sheikh Faisal Bin Saqar Al Qasimi]] [[Chairman of the Board]]<br/> Dr. Ayman Ahmed Sahli [[Chief Executive Officer's |CEO]]|
num_employees = circa 2350 |
num_employees = circa 1740 |
industry = [[Pharmaceutical]]|
industry = [[Pharmaceutical]]|
products = Julphar manufacture and sell more than 423 Products <ref name = AnnualReport2009 >[[Annual Report 2009]][http://julphar.net/Products/English%20annual%20report%202009.pdf]</ref><ref>http://julphar.net/Products.htm</ref>|
products = Julphar manufacture and sell more than 423 Products |
revenue = {{profit}} [[United Arab Emirates Dirham|AED]] 762,041 Thousands <small>(''2009'')</small><ref name="AnnualReport2009"/>|
revenue = {{profit}} [[United Arab Emirates Dirham|AED]] 1,024.1 Million <small>(''2011'')</small>|

operating_income = {{profit}} [[United Arab Emirates Dirham|AED]] 148,452 Thousands <small>(''2009'')</small><ref name= AnnualReport2009/>|
net_income = {{profit}} [[United Arab Emirates Dirham|AED]] 122,518 Thousands <small>(''2009'')</small><ref name= AnnualReport2009/>|
net_income = {{profit}} [[United Arab Emirates Dirham|AED]] 170.2 Million <small>(''2011'')</small>|




homepage = [http://www.Julphar.net/ www.Julphar.net]<ref>http://julphar.net/index.htm</ref>|}}
homepage = [http://www.Julphar.net/ www.Julphar.net]<ref>http://julphar.net/index.htm</ref>|}}


=='''JULPHAR at a glance'''==
'''Gulf Pharmaceutical Industries (Julphar)''' is a [[public shareholding company]] based in the Emirate of [[Ras Al Khaimah]], UAE. It is engaged in the manufacture of pharmaceutical products that address a range of therapeutic segments.
[http://julphar.net/ Julphar] is a public shareholding company based in the Emirate of Ras Al Khaimah, UAE. It was established in the year 1980 under the able guidance of H H Sheikh Saqr Bin Mohammed Al Qasimi, the Ruler of Ras Al Khaimah. It is not only the first pharmaceutical manufacturing company set-up in Arab Gulf States, but also continues to be a leading pharmaceutical producer in the region. <ref name=history>[http://julphar.net/Vision%20of%20Incorporation.htm Company Profile]</ref>


[[File:GoodHealth.jpg‎|288 × 157 pixels|Gulf Pharmaceutical Industries (Julphar) Photo]]
==History==
The Company was established in 1980 under the guidance of H.H.Sheikh [[Saqr bin Mohammad al-Qassimi]] , the Ruler of Ras Al Khaimah.<ref name=history>[http://julphar.net/Vision%20of%20Incorporation.htm Company Profile]</ref>


==Operations==
Julphar is a composite corporation with nine Drug Manufacturing facilities located in UAE.<ref>[http://www.julphar.net/JulpharGroup.htm# Julphar Plants]</ref>


Julphar runs nine production facilities, where its entire range of pharmaceutical products are produced and packed. The nine facilities are devoted to nine different classes of products, together forming the core production facility of the company.


=='''Our Vision'''==
* [[Julphar I]] (Pharmaceutical Solid dosage Forms)
Our endeavour is to ensure the availability of world class, quality medicines at affordable prices, across the globe. We are committed to work towards a healthier & happier world by being one of the leading pharmaceutical companies in the branded generic world
* [[Julphar II]] (B-Lactam Antibiotics & Sterile Dosage Forms )
* [[Julphar III]] (Oral Penicillin Plant)
* [[Julphar IV]] (Oral Cephalosporin Plant)
* [[Julphar V]] (Off-line Packaging Plant)
* [[Julphar VI]] (Liquid & Semi Solid Pharmaceutical Dosage Form)
* [[Julphar VII]] (Biotech Lab and Production Facility)
* [[Julphar VIII]] (Sterile Powder Filling Plant)
* [[Julphar IX]] (Sterile Cephalosporin Powder Filling Plant)


=='''OUR VALUES'''==
==Products==
Julphar has more than 800 formulations and 184 brands under its flag with products in
{| class="wikitable"
every major therapeutic category. Julphar’s product range includes Analgesics, Anti-Malarial, Anti-Biotic, Anti-Amoebic, Ankjkijio iuiu ii
|-
| Integrity || Innovation
|-
| Respect for People || Customer Focus
|-
| Teamwork || Leadership
|-
| Performance || Community <ref>http://julphar.net/</ref>
|}



==References==
=='''History'''==
The Company was established in the year 1980 under the able guidance of H H Sheikh Saqr Bin Mohammed Al Qasimi, the Ruler of [[Ras Al Khaimah]]. His Highness etched his everlasting legacy when he envisioned a pharmaceutical company that will make [[UAE]] self-sufficient in all of its therapeutic needs, providing quality medicine at affordable prices. True to his vision, [http://www.Julphar.net Julphar] has, since its inception, grown into a world class, state-of-the-art pharmaceutical manufacturing company of the Arab World.

Starting with its first plant in 1984, Julphar has rapidly evolved into a true multinational organization with a worldwide marketing network. With nine production facilities located in UAE and its products being marketed across the globe in over 45 countries and 5 continents today, Julphar has truly become a representative of UAE’s entrepreneurial capabilities.

With an illustrious track record of nearly three decades of partnering life and engendering hope, we, at Julphar, believe that access to quality healthcare is a right, not a privilege. Julphar is a people-driven company, with people’s needs at its heart and global markets in its sights. We have always been passionate about our role in the community at large, rising to the emerging challenges and endeavoring to deliver world class pharmaceutical products on time and at affordable prices across the globe. This passion drives our ambition to be the most preferred pharmaceutical products company in all our markets. <ref name=history>[http://julphar.net/Vision%20of%20Incorporation.htm Company Profile]</ref>

=='''Board of Directors'''==
* [[Chairman of the Board]] (H.H. Sheikh Faisal Bin Saqr Al Qasimi)
* [[Vice-Chairman of the Board]] (H.E. Hassan Ahmed Al Alkim)
* [[Members of the Board]] (Sheikh Ahmed Bin Saqr Al Qasimi)
* [[Members of the Board]] (Sheikh Saqr Bin Humaid Al Qasimi)
* [[Members of the Board]] (Mr. Ahmed Essa Al Naem)
* [[Members of the Board]] (Mr. Nawaf Ghobash Ahmed Saeed)
* [[Members of the Board]] (Mr. Mohamed Jamaluddin Al Saati)
* [[Members of the Board]] (Dr. Ali Hussein Al Zawawi)
* [[Members of the Board]] (Mr. Ahmed Salim Al Hosni)
* [[Chief Executive Officer]] (Dr. Ayman Ahmed Sahli)[http://julphar.net/Board%20of%20Directors.htm ]

=='''Julphar World Class Facilities'''==

Julphar’s eleven state-of-the-art drug manufacturing facilities located in UAE adhere to the highest standards of production & manufacturing practices. [http://julphar.net/JulpharGroup.htm Julphar Plants]

Its commitment to quality and a continuous endeavor to surpass its own high standards has resulted in it procuring the ISO 9001 and ISO 14001 certifications. The accreditation of our injection plant by FDA, and the EU-GMP and GLP certifications for all our facilities are a further testimony to our commitment to high quality. These practices and approvals ensure that an effective and well-documented framework is always in place and is strictly followed not only for manufacturing of high quality products, but also for the effective use of resources and reduction of wastes.

In addition to the above, several other support units such as printing & packaging unit, plastic dosing cap and aluminum pilfer-proof cap manufacturing plant, transportation fleet (MENA COOL), carpentry workshop, construction division, design division, etc., form part of the Team Julphar.

* [[Julphar 1]] (Pharmaceutical Solid dosage Forms)
* [[Julphar 2]] (Sterile Liquid & Lyophilized Vials )
* [[Julphar 3]] (Oral ß Lactam Plant)
* [[Julphar 4]] (Oral Cephalosporin Plant)
* [[Julphar 5]] (Offline Packaging Plant)
* [[Julphar 6]] (Liquid Pharmaceutical Dosage Forms)
* [[Julphar 7]] (Biotech Lab and Production Facility)
* [[Julphar 8]] (Liquid & Lyophilized Products)
* [[Julphar 9]] (Sterile Cephalosporin PowderFilling Plant)
* [[Julphar 10]] (Semi Solid Plant)
* [[Julphar 11]] (Human Insulin Plant)

=='''Products'''==
[http://julphar.net/Products.htm ]
Julphar currently has 3,537 products registered in over 50 countries around the globe, with more than 809 formulations and 191 brands. These are cross all the major therapeutic segments. Out of these, over 2,120 product registrations are in the GCC countries, while the rest span other regions, mainly countries in the rest of the Arab world, Asia, Africa, CIS and Latin America. Fifty new product registrations have taken place during the year 2010. There is also a healthy pipeline of new files under preparation.

Julphar’s product range can be divided into the following major categories:

* Anti -Infectives
* Endocrinology
* Respiratory System
* Immunosuppressant
* Nutrition and Blood
* Local Anesthetics
* Cardiovascular Systems
* Central Nervous System
* Musculoskeletal & Joint Diseases
* Oral Cavity & Gastrointestinal Tract
* Skin
* Para-Medical Products ..<ref>[http://julphar.net/Products.htm# Julphar Products]</ref>


=='''Julphar World Wide'''==

* [http://julphar.net/WorldWide.htm Julphar] [[UAE]]
* [http://julphar.net/WorldWide.htm Julphar] [[Saudi Arabia]]
* [http://julphar.net/WorldWide.htm Julphar] [[Qatar]]
* [http://julphar.net/WorldWide.htm Julphar] [[Bahrain]]
* [http://julphar.net/WorldWide.htm Julphar] [[Oman]]
* [http://julphar.net/WorldWide.htm Julphar] [[Iraq]]
* [http://julphar.net/WorldWide.htm Julphar] [[Jordan]]
* [http://julphar.net/WorldWide.htm Julphar] [[Syria]]
* [http://julphar.net/WorldWide.htm Julphar] [[Lebanon]]
* [http://julphar.net/WorldWide.htm Julphar] [[Kuwait]]
* [http://julphar.net/WorldWide.htm Julphar] [[Yemen]]
* [http://julphar.net/WorldWide.htm Julphar] [[Egypt]]
* [http://julphar.net/WorldWide.htm Julphar] [[Sudan]]
* [http://julphar.net/WorldWide.htm Julphar] [[Morocco]]
* [http://julphar.net/WorldWide.htm Julphar] [[Algeria]]
* [http://julphar.net/WorldWide.htm Julphar] [[Tunisia]]
* [http://julphar.net/WorldWide.htm Julphar] [[Libya]]
* [http://julphar.net/WorldWide.htm Julphar] [[Senegal]]
* [http://julphar.net/WorldWide.htm Julphar] [[Ethiopia]]
* [http://julphar.net/WorldWide.htm Julphar] [[Kenya]]
* [http://julphar.net/WorldWide.htm Julphar] [[Uganda]]
* [http://julphar.net/WorldWide.htm Julphar] [[Nigeria]]
* [http://julphar.net/WorldWide.htm Julphar] [[Tanzania]]
* [http://julphar.net/WorldWide.htm Julphar] [[South Africa]]
* [http://julphar.net/WorldWide.htm Julphar] [[Ecuador]]
* [http://julphar.net/WorldWide.htm Julphar] [[Turkey]]
* [http://julphar.net/WorldWide.htm Julphar] [[Pakistan]]
* [http://julphar.net/WorldWide.htm Julphar] [[Afghanistan]]
* [http://julphar.net/WorldWide.htm Julphar] [[Tajikistan]]
* [http://julphar.net/WorldWide.htm Julphar] [[China]]
* [http://julphar.net/WorldWide.htm Julphar] [[Philippines]]
* [http://julphar.net/WorldWide.htm Julphar] [[Thailand]]
* [http://julphar.net/WorldWide.htm Julphar] [[Malaysia]]
* [http://julphar.net/WorldWide.htm Julphar] [[Indonesia]]
* [http://julphar.net/WorldWide.htm Julphar] [[Mauritius]]<ref>[http://julphar.net/WorldWide.htm# Julphar World Wide]</ref>

=='''References'''==
{{Reflist}}
{{Reflist}}

[http://www.julphar.net/annual%20report%202010/index.html Annual Report 2010 (9.47 MB PDF, English and Arabic Version)]

[http://julphar.net/Products/English%20annual%20report%202009.pdf Annual Report 2009 (4.62 MB PDF, English Version)]

[http://julphar.net/Products/annual%20report%202009%20arabic.pdf Annual Report 2009 (6.79 MB PDF, Arabic Version)]


[http://julphar.net/Products/annual%20report%202008%20english.pdf Annual Report 2008 (8.10 MB PDF, English Version)]
[http://julphar.net/Products/annual%20report%202008%20english.pdf Annual Report 2008 (8.10 MB PDF, English Version)]
Line 53: Line 166:
* [http://www.julphar.net/ Official site]
* [http://www.julphar.net/ Official site]






[[Category:Pharmaceutical companies]]
[[Category:Companies of the United Arab Emirates]]
[[Category:Companies of the United Arab Emirates]]

Revision as of 09:26, 9 April 2012

Gulf Pharmaceutical Industries (Julphar)
Company typePublic
IndustryPharmaceutical
Founded1980
HeadquartersRAK, UAE
Key people
Sheikh Faisal Bin Saqar Al Qasimi Chairman of the Board
Dr. Ayman Ahmed Sahli CEO
ProductsJulphar manufacture and sell more than 423 Products
RevenueIncrease AED 1,024.1 Million (2011)
Increase AED 170.2 Million (2011)
Number of employees
circa 1740
Websitewww.Julphar.net[1]

JULPHAR at a glance

Julphar is a public shareholding company based in the Emirate of Ras Al Khaimah, UAE. It was established in the year 1980 under the able guidance of H H Sheikh Saqr Bin Mohammed Al Qasimi, the Ruler of Ras Al Khaimah. It is not only the first pharmaceutical manufacturing company set-up in Arab Gulf States, but also continues to be a leading pharmaceutical producer in the region. [2]

Gulf Pharmaceutical Industries (Julphar) Photo


Our Vision

Our endeavour is to ensure the availability of world class, quality medicines at affordable prices, across the globe. We are committed to work towards a healthier & happier world by being one of the leading pharmaceutical companies in the branded generic world

OUR VALUES

Integrity Innovation
Respect for People Customer Focus
Teamwork Leadership
Performance Community [3]


History

The Company was established in the year 1980 under the able guidance of H H Sheikh Saqr Bin Mohammed Al Qasimi, the Ruler of Ras Al Khaimah. His Highness etched his everlasting legacy when he envisioned a pharmaceutical company that will make UAE self-sufficient in all of its therapeutic needs, providing quality medicine at affordable prices. True to his vision, Julphar has, since its inception, grown into a world class, state-of-the-art pharmaceutical manufacturing company of the Arab World.

Starting with its first plant in 1984, Julphar has rapidly evolved into a true multinational organization with a worldwide marketing network. With nine production facilities located in UAE and its products being marketed across the globe in over 45 countries and 5 continents today, Julphar has truly become a representative of UAE’s entrepreneurial capabilities.

With an illustrious track record of nearly three decades of partnering life and engendering hope, we, at Julphar, believe that access to quality healthcare is a right, not a privilege. Julphar is a people-driven company, with people’s needs at its heart and global markets in its sights. We have always been passionate about our role in the community at large, rising to the emerging challenges and endeavoring to deliver world class pharmaceutical products on time and at affordable prices across the globe. This passion drives our ambition to be the most preferred pharmaceutical products company in all our markets. [2]

Board of Directors

Julphar World Class Facilities

Julphar’s eleven state-of-the-art drug manufacturing facilities located in UAE adhere to the highest standards of production & manufacturing practices. Julphar Plants

Its commitment to quality and a continuous endeavor to surpass its own high standards has resulted in it procuring the ISO 9001 and ISO 14001 certifications. The accreditation of our injection plant by FDA, and the EU-GMP and GLP certifications for all our facilities are a further testimony to our commitment to high quality. These practices and approvals ensure that an effective and well-documented framework is always in place and is strictly followed not only for manufacturing of high quality products, but also for the effective use of resources and reduction of wastes.

In addition to the above, several other support units such as printing & packaging unit, plastic dosing cap and aluminum pilfer-proof cap manufacturing plant, transportation fleet (MENA COOL), carpentry workshop, construction division, design division, etc., form part of the Team Julphar.

Products

[2] Julphar currently has 3,537 products registered in over 50 countries around the globe, with more than 809 formulations and 191 brands. These are cross all the major therapeutic segments. Out of these, over 2,120 product registrations are in the GCC countries, while the rest span other regions, mainly countries in the rest of the Arab world, Asia, Africa, CIS and Latin America. Fifty new product registrations have taken place during the year 2010. There is also a healthy pipeline of new files under preparation.

Julphar’s product range can be divided into the following major categories:

* Anti -Infectives  

*  Endocrinology 

*  Respiratory System      

*  Immunosuppressant  

*  Nutrition and Blood  

*  Local Anesthetics  

*  Cardiovascular Systems 

*  Central Nervous System 

*  Musculoskeletal & Joint Diseases 

*  Oral Cavity & Gastrointestinal Tract 

*  Skin 

*  Para-Medical Products ..[4]


Julphar World Wide

References

Annual Report 2010 (9.47 MB PDF, English and Arabic Version)

Annual Report 2009 (4.62 MB PDF, English Version)

Annual Report 2009 (6.79 MB PDF, Arabic Version)

Annual Report 2008 (8.10 MB PDF, English Version)

Annual Report 2008 (4 MB PDF, Arabic Version)